Influence of β-tricalcium phosphate granule size and morphology on tissue reaction in vivo.

In this study the tissue reaction to five different β-tricalcium phosphate (β-TCP)-based bone substitute materials differing only in size, shape and porosity was analyzed over 60 days, at 3, 10, 15, 30 and 60 days after implantation. Using the subcutaneous implantation model in Wistar rats both the inflammatory response within the implantation bed and the resulting vascularization of the biomaterials were qualitatively and quantitatively assessed by means of standard and special histological staining methods. The data from this study showed that all investigated β-TCP bone substitutes induced the formation of multinucleated giant cells. Changes in size, shape and porosity influenced the integration of the biomaterials within the implantation bed and the formation of tartrate-resistant acid phosphatase (TRAP)-positive and TRAP-negative multinucleated giant cells, as well as the rate of vascularization. While a high porosity generally allowed cell and fiber in-growth within the center of the bone substitute, a lower porosity resulted in a mosaic-like integration of the materials, with the granules serving as place holders. The number of multinucleated giant cells located in the implantation bed positively correlated with the vascularization rate. These data emphasize that all biomaterials investigated were capable of inducing the formation of TRAP-positive multinucleated giant cells as a sign of biomaterial stability. Furthermore, these cells directly influenced vascularization by secretion of vascular endothelial growth factor (VEGF), as well as other chemokines. Based on these findings, the role of multinucleated giant cells in the foreign body reaction to biomaterials might need to be reconsidered. This study demonstrates that variations in the physical properties of a bone substitute material clearly influence the (extent of the) inflammatory reaction and its consequences.

[1]  J. Lane,et al.  Current approaches to experimental bone grafting. , 1987, The Orthopedic clinics of North America.

[2]  M. Bostrom,et al.  Biosynthetic bone grafting. , 1999, Clinical orthopaedics and related research.

[3]  D. F. Williams,et al.  The Williams dictionary of biomaterials , 1999 .

[4]  L. McManus,et al.  Identification and characterization of osteoclast-like cells and their progenitors in cultures of feline marrow mononuclear cells , 1984, The Journal of cell biology.

[5]  Clemens A van Blitterswijk,et al.  Comparative in vivo study of six hydroxyapatite‐based bone graft substitutes , 2008, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[6]  M. Urist,et al.  The bone induction principle. , 1967, Clinical orthopaedics and related research.

[7]  B. Vollmar,et al.  In vivo analysis of biocompatibility and vascularization of the synthetic bone grafting substitute NanoBone. , 2009, Journal of biomedical materials research. Part A.

[8]  P. Henson,et al.  The immunologic release of constituents from neutrophil leukocytes. I. The role of antibody and complement on nonphagocytosable surfaces or phagocytosable particles. , 1971, Journal of immunology.

[9]  C. J. Kirkpatrick,et al.  Experimental approaches to study vascularization in tissue engineering and biomaterial applications , 2003, Journal of materials science. Materials in medicine.

[10]  J. Déjou,et al.  The biodegradation mechanism of calcium phosphate biomaterials in bone. , 2002, Journal of biomedical materials research.

[11]  E. Burger,et al.  Histology of human alveolar bone regeneration with a porous tricalcium phosphate. A report of two cases. , 2001, Clinical oral implants research.

[12]  James M. Anderson,et al.  Lymphocytes and the foreign body response: lymphocyte enhancement of macrophage adhesion and fusion. , 2005, Journal of biomedical materials research. Part A.

[13]  P. Lehner,et al.  Tartrate-resistant Acid Phosphatase (Acp 5): Identification in Diverse Human Tissues and Dendritic Cells , 2001, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[14]  Pamela Habibovic,et al.  Osteoinductive biomaterials—properties and relevance in bone repair , 2007, Journal of tissue engineering and regenerative medicine.

[15]  Y. Doi,et al.  Osteoclastic responses to various calcium phosphates in cell cultures. , 1999, Journal of biomedical materials research.

[16]  E. Nkenke,et al.  Morbidity of harvesting of bone grafts from the iliac crest for preprosthetic augmentation procedures: a prospective study. , 2004, International journal of oral and maxillofacial surgery.

[17]  Jacqueline A. Jones,et al.  Macrophage behavior on surface-modified polyurethanes , 2004, Journal of biomaterials science. Polymer edition.

[18]  J. V. D. van den Bergh,et al.  Maxillary sinus floor augmentation using a beta-tricalcium phosphate (Cerasorb) alone compared to autogenous bone grafts. , 2005, The International journal of oral & maxillofacial implants.

[19]  R. Triplett,et al.  Posterior iliac crest bone harvest: review of technique, complications, and use of an epidural catheter for postoperative pain control. , 2003, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[20]  Elisabeth H Burger,et al.  Localisation of osteogenic and osteoclastic cells in porous beta-tricalcium phosphate particles used for human maxillary sinus floor elevation. , 2005, Biomaterials.

[21]  P. Revell,et al.  The expression of osteoclast markers on foreign body giant cells. , 1994, Bone and mineral.

[22]  R. Detsch,et al.  Formation of osteoclast-like cells on HA and TCP ceramics. , 2008, Acta biomaterialia.

[23]  P. Henson,et al.  The immunologic release of constituents from neutrophil leukocytes. II. Mechanisms of release during phagocytosis, and adherence to nonphagocytosable surfaces. , 1971, Journal of immunology.

[24]  Peter Patka,et al.  Healing of segmental bone defects with granular porous hydroxyapatite augmented with recombinant human osteogenic protein‐I or autologous bone marrow , 2003, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[25]  N. Gellrich,et al.  Comparison of computed tomography and microradiography for graft evaluation after reconstruction of critical size bone defects using beta-tricalcium phosphate. , 2010, Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.

[26]  M. Barbeck,et al.  Histological and histomorphometrical analysis of a silica matrix embedded nanocrystalline hydroxyapatite bone substitute using the subcutaneous implantation model in Wistar rats , 2010, Biomedical materials.

[27]  M. Barbeck,et al.  Fine‐tuning scaffolds for tissue regeneration: effects of formic acid processing on tissue reaction to silk fibroin , 2010, Journal of tissue engineering and regenerative medicine.

[28]  D. Connolly,et al.  Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. , 1989, The Journal of clinical investigation.

[29]  M. Sefton Biomaterials and Clinical Applications , 1988 .

[30]  M. Morlock,et al.  Proinflammatory and osteoclastogenic effects of beta-tricalciumphosphate and hydroxyapatite particles on human mononuclear cells in vitro. , 2009, Biomaterials.

[31]  E. Burger,et al.  Histomorphometry of human sinus floor augmentation using a porous beta-tricalcium phosphate: a prospective study. , 2004, Clinical oral implants research.

[32]  F. Peters,et al.  Functional Materials for Bone Regeneration from Beta‐Tricalcium Phosphate , 2004 .

[33]  C J Damien,et al.  Bone graft and bone graft substitutes: a review of current technology and applications. , 1991, Journal of applied biomaterials : an official journal of the Society for Biomaterials.

[34]  M. Harmsen,et al.  Cellular and molecular dynamics in the foreign body reaction. , 2006, Tissue engineering.

[35]  P. Revell,et al.  Modulation of the phenotypic and functional properties of phagocytic macrophages by wear particles from orthopaedic implants , 1997, Journal of materials science. Materials in medicine.

[36]  C. V. van Blitterswijk,et al.  Critical size defect in the goat's os ilium. A model to evaluate bone grafts and substitutes. , 1999, Clinical orthopaedics and related research.

[37]  N. Athanasou,et al.  Immunophenotypic differences between osteoclasts and macrophage polykaryons: immunohistological distinction and implications for osteoclast ontogeny and function. , 1990, Journal of clinical pathology.

[38]  H. Drexler,et al.  Characterization and expression of tartrate-resistant acid phosphatase (TRAP) in hematopoietic cells. , 1994, Leukemia.

[39]  Benjamin G Keselowsky,et al.  Role of plasma fibronectin in the foreign body response to biomaterials. , 2007, Biomaterials.

[40]  Jacqueline A. Jones,et al.  Vitronectin is a critical protein adhesion substrate for IL-4-induced foreign body giant cell formation. , 2008, Journal of biomedical materials research. Part A.

[41]  K. de Groot Effect of porosity and physicochemical properties on the stability, resorption, and strength of calcium phosphate ceramics. , 1988, Annals of the New York Academy of Sciences.

[42]  Peter Thomsen,et al.  The inflammatory cell influx and cytokines changes during transition from acute inflammation to fibrous repair around implanted materials , 2006, Journal of biomaterials science. Polymer edition.

[43]  M Epple,et al.  A thorough physicochemical characterisation of 14 calcium phosphate-based bone substitution materials in comparison to natural bone. , 2004, Biomaterials.

[44]  James M. Anderson,et al.  Foreign body reaction to biomaterials. , 2008, Seminars in immunology.

[45]  James M. Anderson,et al.  Giant cell formation and function , 2009, Current opinion in hematology.

[46]  V. Young,et al.  Silicone gel-filled breast and testicular implant capsules: a histologic and immunophenotypic study. , 1999, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[47]  James M. Anderson,et al.  Biological Responses to Materials , 2001 .

[48]  W. Bonfield,et al.  Biomechanical assessment of bone ingrowth in porous hydroxyapatite , 1997, Journal of materials science. Materials in medicine.

[49]  B. Cunningham,et al.  Compression strength of donor bone for posterior lumbar interbody fusion. , 1993, Spine.

[50]  A. Sculean,et al.  Clinical and histologic evaluation of granular Beta-tricalcium phosphate for the treatment of human intrabony periodontal defects: a report on five cases. , 2010, Journal of periodontology.

[51]  N. Athanasou,et al.  Immunophenotype of multinucleated and mononuclear cells in giant cell lesions of bone and soft tissue. , 1992, Journal of clinical pathology.

[52]  J. Klawitter,et al.  Application of porous ceramics for the attachment of load bearing internal orthopedic applications , 1971 .

[53]  E Nkenke,et al.  Harvesting of bone from the iliac crest--comparison of the anterior and posterior sites. , 2005, The British journal of oral & maxillofacial surgery.

[54]  D. Prolo,et al.  Quantitative comparisons of healing in cranial fresh autografts, frozen autografts and processed autografts, and allografts in canine skull defects. , 1986, Clinical orthopaedics and related research.

[55]  R. Müller,et al.  Collagen-embedded hydroxylapatite–beta-tricalcium phosphate–silicon dioxide bone substitute granules assist rapid vascularization and promote cell growth , 2010, Biomedical materials.